近5年我国药物性肝损伤患者临床特征分析

张艳梅; 孙文静; 文良志; 刘凯军; 王斌; 刘卉; 陈东风; 傅鑫

doi:10.3969/j.issn.1001-5256.2018.03.023

近5年我国药物性肝损伤患者临床特征分析

DOI: 10.3969/j.issn.1001-5256.2018.03.023

第三军医大学大坪医院野战外科研究所消化内科

详细信息

中图分类号: R575
计量
- 文章访问数: 2762
- HTML全文浏览量: 76
- PDF下载量: 439
- 被引次数: 38
出版历程
- 出版日期: 2018-03-20

Clinical features of patients with drug-induced liver injury in China in the last five years

Department of Gastroenterology, Research Institute of Surgery, Daping Hospital, Third Military Medical University

摘要

摘要:
目的总结分析我国近5年来文献报道的药物性肝损伤（DILI）患者的临床特征。方法检索2012年1月-2016年12月我国DILI相关原始病例报道,并从中纳入202篇相关文献,共计26 015例DILI患者。总结DILI的性别、年龄及地域分布、致病药物、临床特征及预后情况。计数资料以率或构成比描述。结果 26 015例DILI患者中,男12 885例（49.53%）,女13 130例（50.47%）,平均46.86岁。排列前5位的致病药物分别为中药（34.68%）、抗结核药（15.81%）、抗微生物药（12.04%）、抗肿瘤药（9.09%）、解热镇痛药（6.17%）。临床表现主要为乏力（50.37%）、黄疸（52.68%）、纳差（43.59%）。158篇文献记录了19 994例患者DILl的分型,其中肝细胞型占58.84%、胆汁淤积型占21.79%、混合型占19.37%。肝活组织检查在诊断DILI中有一定价值。停用可疑药物,给予抗炎、保肝等综合治疗是DILI的主要治疗方式。179篇文献记录了22 030例患者的预后信息,其中治愈11 159例（50.65%）、好转8742例（39.68%）...
- 药物性肝损伤 /
- MEDLARS /
- 中国
Abstract:
Objective To investigate the clinical features of patients with drug-induced liver injury ( DILI) in China in the last five years.Methods Related databases were searched for original case reports on DILI in China published from January 2012 to December 2017, and a total of 202 articles with 26 015 DILI patients were included in this analysis. Sex, age, geographical distribution, causative drugs, clinical features, and prognosis were summarized and analyzed. Categorical data were expressed as rate ( %) or constituent ratio. Results Of all 26 015 patients, 12 885 ( 49. 53%) were male and 13 130 ( 50. 47%) were female, with a mean age of 46. 86 years. The five most common causative drugs were traditional Chinese medicine ( TCM) ( 34. 68%) , anti-tubercular agents ( 15. 81%) , anti-microbial drugs ( 12. 04%) , antitumor drugs ( 9. 09%) , and analgesic-antipyretic drugs ( 6. 17%) . Major clinical manifestations included fatigue ( 50. 37%) , jaundice ( 52. 68%) , and poor appetite ( 43. 59%) . A total of 158 articles recorded the typing of 19994 DILI patients, among whom 58. 84% had the hepatocellular type, 21. 79% had the cholestasis type, and 19. 37% had the mixed type. Liver biopsy had a certain value in the diagnosis of DILI. Major therapies for DILI included withdrawal of suspected drugs, anti-inflammatory treatment, and liver protection. A total of 179 articles reported the prognosis of 22 030 patients, among whom 11 159 ( 50. 65%) were cured, 8742 ( 39. 68%) were improved, 1176 ( 5. 34%) had no response, and 353 patients ( 1. 60%) died. Conclusion There is a similar incidence rate of DILI between male and female populations. TCM is the most common causative drugs for DILI. The hepatocellular type is the most common clinical type. The cured and improved rate is as high as 90. 34%, and most patients have good prognosis.
- drug-induced liver injury /
- MEDLARS /
- China

HTML全文

参考文献(12)

[1]The Study of Drug Induced Liver Disease of Chinese.Diagnosis and treatment guideline on drug-induced liver injury[J].J Clin Hepatol, 2015, 31 (11) :1752-1769. (in Chinese) 中华医学会肝病学分会药物性肝病学组.药物性肝损伤诊治指南[J].临床肝胆病杂志, 2015, 31 (11) :1752-1769.

[2]CHALASANI NP, HAYASHIPH, BONKOVSKYHL, et al.ACG Clinical Guideline:the diagnosis and management of idiosyncratic drug-induced liver injury[J].Am J Gastroenterol, 2014, 109 (7) :950-966.

[3]REN ZQ, WANG JH, GUO XY, et al.A review analysis of Chinese literatures 2005-2014:clinical features of drug-induced liver injury[J].Chin J Pharmacoepidemiol, 2015, 25 (5) :284-289. (in Chinese) 任张青, 王进海, 郭晓燕, 等.2005~2014年我国药物性肝损伤临床综合分析[J].药物流行病学杂志, 2015, 25 (5) :284-289.

[4]BJORNSSON ES.Drug-induced liver injury due to antibiotics[J].Scand J Gastroenterol, 2017, 52 (6-7) :617-623.

[5]AHMAD J, ODIN JA.Epidemiology and genetic risk factors of drug hepatotoxicity[J].Clin Liver Dis, 2017, 21 (1) :55-72.

[6]ZHOU GQ, LI B, ZENG LL, et al.Clinical features of drug-induced liver injury due to Chinese herbs:an analysis of 80 cases[J].Lishizhen Med Mater Med Res, 2013, 24 (4) :967-968. (in Chinese) 周桂琴, 黎波, 曾玲玲, 等.80例中草药致药物性肝损伤的临床特征分析[J].时珍国医国药, 2013, 24 (4) :967-968.

[7]YAO YJ, LIU HL, ZHU B, et al.Analysis of clinical features and pathological change in 441 patients with drug-induced liver injuries[J].J Pract Hepatol, 2015, 18 (3) :286-289. (in Chinese) 姚云洁, 刘鸿凌, 朱冰, 等.441例药物性肝损伤患者临床和肝组织病理学特征分析[J].实用肝脏病杂志, 2015, 18 (3) :286-289.

[8]FRENZEL C, TESCHKE R.Herbal hepatotoxicity:clinical characteristics and listing compilation[J].Int J Mol Sci, 2016, 17 (5) :588.

[9]WAN B, ZENG YL, CHEN Z, et al.Clinical features and nursing measures of 54 children with drug-induced liver injury caused by antituberculosis treatment[J/CD].Chin J Liver Dis:Electronic Edition, 2016, 2 (8) :34-38. (in Chinese) 万彬, 曾义岚, 陈竹, 等.54例抗结核药致儿童药物性肝损伤的临床特点及护理[J/CD].中国肝脏病杂志:电子版, 2016, 2 (8) :34-38.

[10]XU ZL, GAO M, GUO CX, et al.Clinical features of different types of drug-induced liver injury and their association with liver histological changes[J].J Clin Hepatol, 2017, 33 (5) :924-927. (in Chinese) 徐曾丽, 高敏, 郭春霞, 等.药物性肝损伤临床分型特点及其与肝组织学改变的关系[J].临床肝胆病杂志, 2017, 33 (5) :924-927.

[11]LI J.Clinical features and treatment of drug-induced hepatitis:an analysis of 228 cases[J].China Prac Med, 2016, 11 (2) :173-174. (in Chinese) 李菁.228例药物性肝炎临床分析及治疗[J].中国实用医药, 2016, 11 (2) :173-174.

[12]ZHANG CP, CUI XL, WANG YM.Retrospective analysis of 200patients with drug induced liver injury[J].Chin Hepatol, 2014, 19 (7) :483-486. (in Chinese) 张长平, 崔向丽, 王咏梅.药物性肝损伤200例临床分析[J].肝脏, 2014, 19 (7) :483-486.

施引文献

期刊类型引用(21)

1.	CAO Wei Hua，JIANG Ting Ting，SHEN Ge，DENG Wen，WANG Shi Yu，ZHANG Zi Yu，LI Xin Xin，LU Yao，ZHANG Lu，LIU Ru Yu，CHANG Min，WU Shu Ling，GAO Yuan Jiao，HAO Hong Xiao，CHEN Xiao Xue，HU Lei Ping，XU Meng Jiao，YI Wei，XIE Yao，LI Ming Hui. Association of Cytokines with Clinical Indicators in Patients with Drug-Induced Liver Injury. Biomedical and Environmental Sciences. 2024(05): 494-502 . 必应学术
2.	黄芳. 宁德市近10年药物性肝损伤不良反应报告分析. 药物评价研究. 2024(12): 2874-2880 . 百度学术
3.	赵睿婷，陈静，闫翔. 牛髓粉所致药物性肝损伤1例诊疗分析并文献复习. 医学理论与实践. 2023(04): 716-718 . 百度学术
4.	田娜妮，何青青，朱琳，姚杨，惠娇娇，梁乐，白婷，杨蕊，李霄. 83例药物性肝损伤回顾性分析及保肝药的应用分析. 中国医药导刊. 2023(02): 205-209 . 百度学术
5.	李响，高婧，暴海洋，朱艳秋，陈艳辉，王兴华. 化疗前外周血lncRNAs表达水平对抗结核药物肝损伤的预测价值. 肝脏. 2023(03): 346-350 . 百度学术
6.	蔡静，周桂琴，曹亦楠，刘亚兴，王晓静，冯颖，王宪波. 247例中草药相关肝损伤伴或不伴自身抗体阳性患者临床特征对比分析. 中西医结合肝病杂志. 2023(04): 303-306+310 . 百度学术
7.	付双楠，何婷婷，张宁，周超，张晶晶，王宣，李昕，孙志华，刘鹏程，宫嫚. 15例急性药物性肝损伤伴急性肾损伤患者的临床特征分析. 肝脏. 2021(08): 895-898 . 百度学术
8.	马晓瑞，李红霞，马利. 348例药物性肝损害的临床分析. 西安交通大学学报(医学版). 2021(06): 909-914 . 百度学术
9.	王洁，宋艳艳，李颖，张江红，杨新强，乔逸，杨志福，文爱东. 104例药物性肝损伤的病例分析. 中国药物应用与监测. 2020(01): 37-40+66 . 百度学术
10.	任姗，杜晓菲，黄云丽，黄春洋，张晓丹，单晶，陈新月. 药物性肝损伤伴自身免疫现象患者血清γ干扰素诱导蛋白10水平及其单核苷酸多态性. 临床肝胆病杂志. 2020(03): 602-607 . 本站查看
11.	李颖，邹吉利，江洁，朱丽，熊迪. 2020年武汉市第三医院新型冠状病毒肺炎患者药物相关肝功能异常分析. 现代药物与临床. 2020(10): 2073-2078 . 百度学术
12.	陈琦琪，陆慧慧，孙芳芳，张璐，路遥. 药物性肝损伤慢性化研究进展. 中国肝脏病杂志(电子版). 2020(04): 38-42 . 百度学术
13.	梁栋，董晓锋，张燕，朱晓红，王建斌，刘妲妲，柳伟伟，方圆，王全楚. 98例药物性肝损伤的临床特点及诊疗体会. 肝脏. 2019(04): 389-391 . 百度学术
14.	邬丽娜，宋毓飞，张谢，黄诗良，沈晓伶，张学松. 采用RUCAM量表评价259例药物性肝损伤临床研究. 现代实用医学. 2019(06): 730-731 . 百度学术
15.	郭立杰，张海丛，叶立红，王超，杜婧，伍彦辉. 中西药所致药物性肝损伤临床及病理特点分析. 临床误诊误治. 2019(08): 28-33 . 百度学术
16.	陈国凤，纪冬. 重视药物性肝损伤的临床研究. 医学研究杂志. 2019(09): 1-4+61 . 百度学术
17.	解鑫赫，赵瑞玲. 药物性肝损伤临床诊断的研究进展. 医学综述. 2019(20): 4044-4048+4054 . 百度学术
18.	王静，马园园，刘成海，陶艳艳. 基于文献的药物性肝损伤流行病学分析. 中西医结合肝病杂志. 2019(05): 452-455+458 . 百度学术
19.	方志雄，张海明，陈军. 药物性肝损伤诊治现状和进展. 现代医药卫生. 2018(13): 1944-1948 . 百度学术
20.	吴宇宇，袁苏榆，孙四珍，王岁晶，丁洋. 药物性肝损伤诊断治疗进展概述. 药物流行病学杂志. 2018(08): 550-555 . 百度学术
21.	李晨，苏海滨，刘晓燕，许祥，李会，胡瑾华. 急性药物性肝损伤发展为慢性药物性肝损伤合并自身免疫性肝炎样表现1例报告. 临床肝胆病杂志. 2018(10): 2200-2202 . 本站查看